OMG Pharma Leads World-First Trial to Clinically Assess Topical Medicinal Cannabis for Rheumatoid Arthritis
Australian biotechnology company OMG Pharma, a division of the Oz Medicann Group, has announced the commencement of a world-first clinical study in partnership with the National Institute of Complementary Medicine (NICM Health Research Institute) at Western Sydney University. The trial investigates the efficacy of a CBD-based topical salve in reducing pain and inflammation in people living with rheumatoid arthritis, an autoimmune condition […]
Oz Medicann Group’s OMG Pharma Wins Cannabiz Award for Best Product Launch 2024
SYDNEY, Australia – OMG Pharma Australia (OMG), the scientific arm of the Oz Medicann Group and an architect in the Australian biotech scene specialising in cannabinoid medicine, is excited to announce a landmark partnership with global industry leader dsm- firmenich. This strategic collaboration aims to transform the treatment landscape for insomnia with an innovative, pharmaceutical-grade CBD […]
Oz Medicann Group Announces Groundbreaking AI Innovation “asksam™” to Revolutionize Healthcare
Sydney, Australia – May 18, 2024 – Oz Medicann Group, a leader in cannabinoid medicine and biotech innovation, is thrilled to announce the launch of “Ask Sam,” a revolutionary AI-powered bot designed to transform patient care and streamline medical operations. This cutting-edge technology represents a significant leap forward in personalised healthcare, promising to enhance the efficiency […]
OMG Pharma Australia and dsm-firmenich Embark on a Transformative Partnership for Insomnia CBD Treatment as an Integral Part of the Oz Medicann Group’s Vision
SYDNEY, Australia – OMG Pharma Australia (OMG), the scientific arm of the Oz Medicann Group and an architect in the Australian biotech scene specialising in cannabinoid medicine, is excited to announce a landmark partnership with global industry leader dsm- firmenich. This strategic collaboration aims to transform the treatment landscape for insomnia with an innovative, pharmaceutical-grade CBD […]